ASH Impact Series: Paul Richardson, MD - Examining the New FDA Approved Myeloma Drug Products

7/14/2016

Description

Paul Richardson, MD, discusses the new therapies for multiple myeloma that were approved by the FDA in November 2015, as well as his participation in the ASH/FDA Joint Symposium on Late-Breaking Drug Approvals at the 2015 ASH Annual Meeting. Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

Speakers

  • Paul Richardson, MD

back to top